HAII Secures MFDS Approval for Confirmatory Clinical Trials of Dementia Diagnostic Digital Device
HAII becomes the first in South Korea to receive MFDS approval for clinical trials of its diagnostic digital device, Alzguard, which uses digital biomarkers like voice, eye movement, and cognitive response for early detection.
HAII Collaborates with Startup Spin-off from National Pension Service
HAII has entered a strategic sales partnership with Startfolio, a spin-off from the National Pension Service, to promote its digital healthcare products such as ‘Mind Garden’ and ‘Alzguard’ to over 6,000 public institutions across Korea.
@Copyright 2022. All Right Reserved. Hosted by Imweb
